Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy
Clinical trial NCT05386160 · UNKNOWN
Trial details
- NCT number
- NCT05386160
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2023-03-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.